The Effects of Add-On Low-Dose Memantine on Cytokine Levels in Bipolar II Depression
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Effects of Add-On Low-Dose Memantine on Cytokine Levels in Bipolar II Depression
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
Volume 34, Issue 3, Pages 337-343
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-04-09
DOI
10.1097/jcp.0000000000000109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder
- (2014) Johan Söderlund et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Cytokines in bipolar disorder: A systematic review and meta-analysis
- (2012) Klaus Munkholm et al. JOURNAL OF AFFECTIVE DISORDERS
- The ‘true’ prevalence of bipolar II disorder
- (2011) Kathleen R. Merikangas et al. CURRENT OPINION IN PSYCHIATRY
- The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: Findings from a 12-month naturalistic trial
- (2011) Athanasios Koukopoulos et al. JOURNAL OF AFFECTIVE DISORDERS
- Low-Dose Memantine Attenuated Morphine Addictive Behavior Through its Anti-Inflammation and Neurotrophic Effects in Rats
- (2011) Shiou-Lan Chen et al. Journal of Neuroimmune Pharmacology
- Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model
- (2011) M.-N. Quan et al. NEUROSCIENCE
- Manic Symptoms During Depressive Episodes in 1,380 Patients With Bipolar Disorder: Findings From the STEP-BD
- (2009) Joseph F. Goldberg et al. AMERICAN JOURNAL OF PSYCHIATRY
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
- (2009) Lakshmi N Yatham et al. BIPOLAR DISORDERS
- Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
- (2009) Elisa Brietzke et al. JOURNAL OF AFFECTIVE DISORDERS
- Double-Blind, Randomized Comparison of Memantine and Escitalopram for the Treatment of Major Depressive Disorder Comorbid With Alcohol Dependence
- (2009) Leea H. Muhonen et al. JOURNAL OF CLINICAL PSYCHIATRY
- Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder
- (2009) Benjamin I. Goldstein et al. JOURNAL OF CLINICAL PSYCHIATRY
- Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation
- (2009) Hung-Ming Wu et al. NEUROPSYCHOPHARMACOLOGY
- The potential use of biomarkers as an adjunctive tool for staging bipolar disorder
- (2009) Flávio Kapczinski et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A Discriminating Messenger RNA Signature for Bipolar Disorder Formed by an Aberrant Expression of Inflammatory Genes in Monocytes
- (2008) Roos C. Padmos et al. ARCHIVES OF GENERAL PSYCHIATRY
- Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study
- (2008) Fabiano G. Nery et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents
- (2008) C CHIPANA et al. NEUROPHARMACOLOGY
- A systematic review of off-label uses of memantine for psychiatric disorders
- (2008) Kristina Zdanys et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- TNF-α as a molecular target in bipolar disorder
- (2008) Elisa Brietzke et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now